EDGAR Filing Documents for 0001123292-18-000970

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001123292-18-000970

Filing Date

2018-09-24

Accepted

2018-09-24 16:26:28

Documents

Period of Report

2018-09-01

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	edgar.html	4
1	PRIMARY DOCUMENT	edgar.xml	4	5555
	Complete submission text file	0001123292-18-000970.txt		7109

Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915

Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125

Innovation Pharmaceuticals Inc. (Issuer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 CUMMINGS CENTER, SUITE 151-B BEVERLY MA 01915

Business Address

Type: 4 | Act: 34 | File No.: 001-37357 | Film No.: 181083798